Movement Disorders - Treatment & Services
Temple University Hospital Neuroscience Center’s Movement Disorders Program is a premier program in the region for evaluating and treating patients with all forms of movement disorders. The Center, at Boyer Pavilion, builds on Temple’s rich history of pioneering in the treatment of movement disorders. A highly skilled, multidisciplinary medical team of neurologists and neurosurgeons in consultation with physical therapists, psychiatrists and rehabilitation physicians offers comprehensive diagnostic and treatment capabilities that provide patients with the most advanced treatments available today.
Temple’s program provides diagnosis and treatment of movement disorders using the most advanced diagnostic tools, including 3 Tesla, functional and molecular MRI; neuropsychiatric, mobility and balance assessments; and comprehensive measures of disease severity for each of the following disorders:
- Parkinson’s disease
- Essential and other types of tremor
- Tourette’s syndrome
- Huntington’s Chorea
- Wilson’s disease
- Advanced treatment paradigms and therapy medications. Temple Movement Disorders is on the cutting edge of the newly-breaking drug therapies that frequently emerge
- Botulinum Toxin (Botox)® injections for essential tremor and dystonia. Research indicates that about 70% of patients treated with Botox® show some improvement in tremor. Botulinum has become the treatment of choice for blepharospasm and hemifacial spasm. Parkinsonian patients with belpharospasm and dystonic foot inversion also may benefit from Botulinum therapy
When drug therapy is no longer effective, patients with Parkinson’s disease, essential tremor, dystonia and other movement disorders may be candidates for Deep Brain Stimulation (DBS).
DBS is associated with significant improvement of motor symptoms of severe Parkinson’s disease, including walking, tremor, rigidity and dyskinesia. Results demonstrate significant and clinically measurable quality of life improvement in patients who suffer severe fluctuations in mobility and dyskinesias. DBS for patients with essential tremor results in dramatic quality of life improvements and tremor reduction.
Temple’s two-stage treatment method may be easier for patients to tolerate, with possible fewer hospital days and shorter rehabilitation.
Genetic counselors provide genetic information and psychosocial support to individuals and families with a genetic condition or those at risk to develop a genetic condition.
Temple Movement Disorders offers patients many opportunities to participate in research. For information about current trials for patients with movement disorders, call the clinical research coordinator at 215-707-7845.
Movement Disorders Program Faculty:
Tinatin Chabrashvili, MD, PhD, Program Director
S. Ausim Azizi, MD, PhD, Chair, Neurology
Ernesto Cruz, MD, Physical Medicine & Rehabilitation
Natalia Ortiz-Torrent, MD, Psychiatry